Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$640M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$501M |
| 3 |
Digital Realty Trust
DLR
|
+$438M |
| 4 |
Intuitive Surgical
ISRG
|
+$437M |
| 5 |
Amazon
AMZN
|
+$420M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$545M |
| 2 |
DexCom
DXCM
|
+$457M |
| 3 |
AT&T
T
|
+$431M |
| 4 |
Palo Alto Networks
PANW
|
+$416M |
| 5 |
Humana
HUM
|
+$394M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.03% |
| 2 | Healthcare | 2.92% |
| 3 | Consumer Discretionary | 1.99% |
| 4 | Financials | 1.93% |
| 5 | Industrials | 1.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
11501
CALL
Heritage Insurance Holdings
HRTG
$1.01B
| $60.4K | ﹤0.01% |
15,700
-57,100
| -78% | -$229K |
|
11502
CALL
CytomX Therapeutics
CTMX
$732M
| $60.4K | ﹤0.01% |
35,100
+20,500
| +140% | +$34K |
|
11503
CALL
908 Devices
MASS
$414M
| $60.4K | ﹤0.01% |
8,800
+5,900
| +203% | +$47.4K |
|
11504
CALL
Envela
ELA
$416M
| $60.4K | ﹤0.01% |
8,200
-700
| -8% | -$4.87K |
|
11505
SouthState Bank Corp
SSB
$10.8B
| $60.3K | ﹤0.01% |
917
-9,112
| -91% | -$608K |
|
|
FOLD
11506
DELISTED
Amicus Therapeutics
FOLD
| $60.3K | ﹤0.01% |
4,799
-499,177
| -99% | -$5.92M |
|
|
MACK
11507
PUT
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $60.3K | ﹤0.01% |
4,900
-14,600
| -75% | -$183K |
|
|
APRN
11508
CALL
DELISTED
Blue Apron Holdings, Inc. Class A Common Stock
APRN
| $60.2K | ﹤0.01% |
10,304
-18,288
| -64% | -$124K |
|
11509
CALL
Inogen
INGN
$153M
| $60.1K | ﹤0.01% |
5,200
+3,000
| +136% | +$35.4K |
|
11510
Cellectar Biosciences
CLRB
$24.6M
| $60K | ﹤0.01% |
+1,026
| New | +$49.4K |
|
11511
Bioventus
BVS
$1.2B
| $59.9K | ﹤0.01% |
+20,724
| New | +$39.8K |
|
11512
Myomo
MYO
$68.1M
| $59.9K | ﹤0.01% |
115,522
+65,293
| +130% | +$36.3K |
|
|
LILM
11513
PUT
DELISTED
Lilium N.V. Class A Ordinary Shares
LILM
| $59.8K | ﹤0.01% |
34,000
+9,300
| +38% | +$8.67K |
|
11514
CALL
International General Insurance
IGIC
$1.16B
| $59.8K | ﹤0.01% |
6,700
+3,600
| +116% | +$31K |
|
11515
WidePoint Corp
WYY
$94.5M
| $59.8K | ﹤0.01% |
32,129
+5,785
| +22% | +$10.7K |
|
11516
Hitek Global
HKIT
$28M
| $59.7K | ﹤0.01% |
+3
| New | +$79.9K |
|
11517
Crexendo
CXDO
$221M
| $59.7K | ﹤0.01% |
33,943
-5,347
| -14% | -$8.57K |
|
|
GRTS
11518
CALL
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $59.7K | ﹤0.01% |
30,600
-98,800
| -76% | -$231K |
|
11519
CALL
Puma Biotechnology
PBYI
$456M
| $59.7K | ﹤0.01% |
16,900
+1,700
| +11% | +$5.3K |
|
11520
PUT
SEI Investments
SEIC
$12.8B
| $59.6K | ﹤0.01% |
1,000
-4,700
| -82% | -$273K |
|
11521
Focus Universal
FCUV
$3.95M
| $59.6K | ﹤0.01% |
97
+19
| +24% | +$13.3K |
|
11522
PUT
China Automotive Systems
CAAS
$142M
| $59.5K | ﹤0.01% |
12,100
+1,600
| +15% | +$7.76K |
|
11523
PUT
Vanguard Extended Market ETF
VXF
$32.3B
| $59.5K | ﹤0.01% |
400
-400
| -50% | -$56.1K |
|
11524
Biomerica
BMRA
$4.88M
| $59.5K | ﹤0.01% |
5,470
+2,019
| +59% | +$23.9K |
|
|
CHCT
11525
CALL
Community Healthcare Trust
CHCT
$432M
| $59.4K | ﹤0.01% |
1,800
+1,700
| +1,700% | +$59.1K |
|
Similar funds
Citadel Advisors's Q2 2023 Portfolio in Review
As of Q2 2023, Citadel Advisors held 15,826 positions worth $484B, up 6.4% from $455B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Citadel Advisors withdrew a net $16.6B in Q2 2023, closing 1,562 positions and reducing 7,223 holdings. Its most notable exit was State Street Industrial Select Sector SPDR ETF, an estimated $192M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3.2% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Citadel Advisors opened a new position in BILL Holdings worth $222M.
- Citadel Advisors's largest Q2 2023 buy was BILL Holdings: 1,901,064 shares worth $222M.
- Citadel Advisors added most to Microsoft in Q2 2023, an estimated $640M increase.
- Citadel Advisors's biggest Q2 2023 reduction was NVIDIA, cutting an estimated $545M.
- Citadel Advisors fully exited State Street Industrial Select Sector SPDR ETF in Q2 2023, selling an estimated $192M.
- Citadel Advisors's ten largest holdings make up 36% of its $484B portfolio in Q2 2023.
- Citadel Advisors opened 1,205 new positions and closed 1,562 in Q2 2023.
- Citadel Advisors's portfolio value rose 6.4% quarter-over-quarter to $484B.
Based on Citadel Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.